Aarti Drugs Ltd - AARTI DRUGS Share Price

Sector: Pharmaceuticals | ISIN: INE767A01016
₹ 552.55 (0.21%) icon26 Sep, 2023, 12:05:34 PM

Aarti Drugs Ltd Stock View

info icon
Edit Image
BUY
Target | 25 Jul, 2023 520.333 (-5.63%)

Aarti Drugs Limited is an India-based company that is engaged in the manufacturing of active pharmaceutical ingredients (APIs), pharma intermediates, specialty chemicals and formulations. Th... Read More

Aarti Drugs Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 9/26/2023 12:05:34 PM

    ₹ 552.55 1.15 0.21
  • Open
  • ₹ 551.5
  • Prev. Close
  • ₹ 551.4
  • Turnover(Lac.)
  • ₹ 312
  • Day's High
  • ₹ 557.9
  • Day's Low
  • ₹ 550.6
  • 52 Week's High
  • ₹ 645.75
  • 52 Week's Low
  • ₹ 313.9
  • Book Value
  • ₹ 124.61
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 5,116.61
  • P/E
  • 30.81
  • EPS
  • 17.93
  • Divi. Yield
  • 0.18

Aarti Drugs Ltd Corporate Actions

04 Sep , 2023

12:00 AM

AGM

Announcement date: 04 Sep , 2023

View Details

14 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

14 Jul , 2023

12:00 AM

23 Apr , 2023

12:00 AM

23 Apr , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

27 Jan , 2023

12:00 AM

Dividend

Dividend amount: 1
Announcement date: 27 Jan , 2023

View Details

20 Jan , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

20 Jan , 2023

12:00 AM

13 Oct , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

13 Oct , 2022

12:00 AM

26 Sep , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

Aarti Drugs Ltd News and Update

Image not found
  • 22 September, 2023 |
  • 8:26 PM

Nirma Ltd. will conduct a required open offer to all public shareholders of GLS in accordance with SEBI regulations.

Article Image
  • IIFL News Service |
  • 22 September, 2023 |
  • 8:26 PM
Image not found
Image not found
  • IIFL News Service |
  • 21 September, 2023 |
  • 8:24 PM

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Aarti Drugs Ltd SHAREHOLDING SNAPSHOT
26 September , 2023 | 12:05 PM

PROMOTER - TOTAL58.70%

Indian: 58.70%

Foreign: 0%

NON-PROMOTER - TOTAL 41.30%

Institutions: 6.68%

Non-Institutions: 34.62%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Aarti Drugs Ltd FINANCIALS

Aarti Drugs Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Aarti Drugs Ltd

  • Prakash M Patil
  • CMD & Executive Director
  • Rashesh C Gogri
  • ED / MD / Promoter
  • Harshit M Savla
  • ED / Joint MD / Promoter
  • Harit P Shah
  • E D & Wholetime Director
  • Uday M Patil
  • WTD & Executive Director
  • Narendra Jagannath Salvi
  • Non Executive Director
  • Navin Chapshi Shah
  • Independent Non Exe. Director
  • Krishnacharya G Akamanchi
  • Independent Non Exe. Director
  • Priti Savla
  • Independent Non Exe. Director
  • Ankit Vikram Paleja
  • Independent Non Exe. Director
  • Bhaskar Narayan Thorat
  • Independent Non Exe. Director
  • Neha Gada
  • Independent Non Exe. Director

Summary

Aarti Drugs Limited (ADL) is a prominent manufacturer of APIs, Pharma Intermediates, and Specialty Chemicals. The Company operates as part of the Aarti Group, a conglomerate with a net worth of USD 900 million. With over 50 compounds for Antibiotics, Anti Protozoal, Anti-Inflammatory, Anti-diabetic, Anti Fungal and Cardioprotectant therapeutic segments, the Company has emerged as market leader in APIs. It has a wholly-owned subsidiary called Pinnacle Life Science Private Limited which operates in the field of manufacturing formulations. The Company has two R&D divisions, one in Tarapur and the other in Turbhe, Maharashtra. It has 3 subsidiaries, namely, Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SpA (foreign subsidiary). Of the above subsidiaries, Pinnacle Life Science Private Limited and Aarti Speciality Chemicals Limited are wholly owned subsidiaries.The manufacturing units of the Company are GMP certified. Their products include Active Pharmaceutical Ingredients (APIs), Steroids, Pharmaceutical Intermediates, and Specialty Chemicals, such as Benzene Sulphonyl Chloride, Benzene Sulphonic Acid/ Ammonium/ Sodium Salt and Benzene Sulphonamide. Aarti Drugs Ltd, a part of Aarti Group of Industries, was incorporated in September 28th, 1984. In the year 1993, the company implemented the second phase of their backward integration project and set up facilities for glyoxal (the main raw material for imidazoles). During the year... Read More


Reports by Aarti Drugs Ltd


Reports by Aarti Drugs Ltd

Company FAQ

No Record Found